{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:06:39Z","timestamp":1793171199629,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Several studies have reported the association of the SNP rs2414096 in the CYP19 gene with hyperandrogenism, which is one of the clinical manifestations of polycystic ovary syndrome (PCOS). These studies suggest that SNP rs2414096 may be involved in the etiopathogenisis of PCOS. To investigate whetherthe CYP19 gene SNP rs2414096 polymorphism is associated with the susceptibility to PCOS, we designed a case-controlled association study including 684 individuals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A case-controlled association study including 684 individuals (386 PCOS patients and 298 controls) was performed to assess the association of SNP rs2414096 with PCOS. Genotyping of SNP rs2414096 was conducted by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method that was performed on genomic DNA isolated from blood leucocytes. Results were analyzed in respect to clinical test results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The genotypic distributions of rs2414096 (GG, AG, AA) in the CYP19 gene (GG, AG, AA) in women with PCOS (0.363, 0.474, 0.163, respectively) were significantly different from that in controls (0.242, 0.500, 0.258, respectively) (<jats:italic>P<\/jats:italic> = 0.001). E2\/T was different between the AA and GG genotypes. Age at menarche (AAM) and FSH were also significantly different among the GG, AG, and AA genotypes in women with PCOS (P = 0.0391 and 0.0118, respectively). No differences were observed in body mass index (BMI) and other serum hormone concentrations among the three genotypes, either in the PCOS patients or controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggest that SNP rs2414096 in the CYP19 gene is associated with susceptibility to PCOS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-10-139","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T07:15:07Z","timestamp":1261034107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women"],"prefix":"10.1186","volume":"10","author":[{"given":"Jia-Li","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,16]]},"reference":[{"key":"553_CR1","doi-asserted-by":"publisher","first-page":"26380","DOI":"10.1074\/jbc.M300688200","volume":"278","author":"JR Wood","year":"2003","unstructured":"Wood JR, Nelson VL, Ho C: The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem. 2003, 278: 26380-26390. 10.1074\/jbc.M300688200.","journal-title":"J Biol Chem"},{"issue":"2","key":"553_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","volume":"8","author":"DA Dumesic","year":"2007","unstructured":"Dumesic DA, Abbott DH, Padmanabhan V: Abbott and Vasantha Padmanabhan. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord. 2007, 8 (2): 127-41. 10.1007\/s11154-007-9046-0.","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"553_CR3","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/deh900","volume":"20","author":"CJ Petry","year":"2005","unstructured":"Petry CJ, Ong KK, Michelmore KF, et al: Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Human Reproduction. 2005, 20 (7): 1837-1843. 10.1093\/humrep\/deh900.","journal-title":"Human Reproduction"},{"key":"553_CR4","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1210\/jc.2005-0330","volume":"90","author":"J K Wickenheisser","year":"2005","unstructured":"Wickenheisser J, Nelson-DeGrave V, Hendricks K, Legro R: Retinoids and Retinol Differentially Regulate Steroid Biosynthesis in Ovarian Theca Cells Isolated from Normal Cycling Women and Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2005, 90: 4858-4865. 10.1210\/jc.2005-0330.","journal-title":"J Clin Endocrinol Metab"},{"key":"553_CR5","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998, 83: 3078-3082. 10.1210\/jc.83.9.3078.","journal-title":"J Clin Endocrinol Metab"},{"key":"553_CR6","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1210\/jc.79.4.1158","volume":"79","author":"C Gilling-Smith","year":"1994","unstructured":"Gilling-Smith C, Willis DS, Beard RW: Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 1994, 79: 1158-1165. 10.1210\/jc.79.4.1158.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"553_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humupd\/dmi025","volume":"11","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C: Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Human Reproduction Update. 2005, 11 (6): 631-643. 10.1093\/humupd\/dmi025.","journal-title":"Human Reproduction Update"},{"key":"553_CR8","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.fertnstert.2006.04.027","volume":"86","author":"M R Jones","year":"2006","unstructured":"Jones M, Italiano L, Wilson S: Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril. 2006, 86: 1438-46. 10.1016\/j.fertnstert.2006.04.027.","journal-title":"Fertil Steril"},{"key":"553_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1210\/jc.2003-031640","volume":"89","author":"M Gaasenbeek","year":"2004","unstructured":"Gaasenbeek M, Powell BL, Sovio U, Haddad L: Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab. 2004, 89: 2408-13. 10.1210\/jc.2003-031640.","journal-title":"J Clin Endocrinol Metab"},{"key":"553_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","volume":"71","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Bartzis M, Zapanti ED: Polymorphism T\u2192C (34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril. 1999, 71: 431-5. 10.1016\/S0015-0282(98)00512-3.","journal-title":"Fertil Steril"},{"key":"553_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/molehr\/gal022","volume":"3","author":"L Jin","year":"2006","unstructured":"Jin L, Zhu X-M, Luo Q: A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS. Molecular Human Reproduction. 2006, 3: 151-155. 10.1093\/molehr\/gal022.","journal-title":"Molecular Human Reproduction"},{"issue":"3","key":"553_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","volume":"6","author":"N Gharani","year":"1997","unstructured":"Gharani N, Waterworth D, Batty S, White D: Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Human Molecular Genetics. 1997, 6 (3): 397-402. 10.1093\/hmg\/6.3.397.","journal-title":"Human Molecular Genetics"},{"issue":"16","key":"553_CR13","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/hmg\/ddl155","volume":"15","author":"Y Guo","year":"2006","unstructured":"Guo Y, Xiong DH, Yang TL: Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. Human Molecular Genetics. 2006, 15 (16): 2401-2408. 10.1093\/hmg\/ddl155.","journal-title":"Human Molecular Genetics"},{"key":"553_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amjmed.2006.07.003","volume":"119","author":"MR Sowers","year":"2006","unstructured":"Sowers MR, Wilson AL, Kardia SR, Chu J, Ferrell R: Aromatase gene (CYP19) polymorphisms and endogenous androgen concentrations in a multiracial\/multiethnic, multisite study of women at midlife. Am J Med. 2006, 119: 23-30. 10.1016\/j.amjmed.2006.07.003.","journal-title":"Am J Med"},{"key":"553_CR15","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term healt h risks related to polycystic ovary syndrome[J]. Fertil Steril. 0000, 81 (1): 19-25. 10.1016\/j.fertnstert.2003.10.004.","DOI":"10.1093\/humrep\/deh098"},{"issue":"16","key":"553_CR16","first-page":"3051","volume":"37","author":"N Harada","year":"1992","unstructured":"Harada N: The structural and functional characterization of P-450.aromatase (estrogen synthetase). Tanpakushitsu Kakusan Koso. 1992, 37 (16): 3051-9.","journal-title":"Tanpakushitsu Kakusan Koso"},{"issue":"24","key":"553_CR17","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1073\/pnas.90.24.11673","volume":"90","author":"Y Ito","year":"1993","unstructured":"Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER: Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA. 1993, 90 (24): 11673-7. 10.1073\/pnas.90.24.11673.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"553_CR18","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1210\/jc.2003-030433","volume":"88","author":"A Belgorosky","year":"2003","unstructured":"Belgorosky A, Pepe C, Marino R, Guercio G, Saraco N, Vaiani E, Rivarola MA: Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab. 2003, 88 (11): 5127-31. 10.1210\/jc.2003-030433.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"553_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/oxfordjournals.humrep.a019405","volume":"11","author":"K Takayama","year":"1996","unstructured":"Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, Wada Y, Yajima A: Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod. 1996, 11 (7): 1387-92.","journal-title":"Hum Reprod"},{"issue":"4","key":"553_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/humrep\/deh690","volume":"20","author":"D S\u00f6derlund","year":"2005","unstructured":"S\u00f6derlund D, Canto P, Carranza-Lira S, Me\u0144dez JP: No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Human Reproduction. 2005, 20 (4): 965-969. 10.1093\/humrep\/deh690.","journal-title":"Human Reproduction"},{"key":"553_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.toxlet.2005.11.014","volume":"164","author":"F Siqueira Ribeiro","year":"2006","unstructured":"Siqueira Ribeiro F, da Fonte de Amorim LM, de Almeida Sim\u00e3o T, Azevedo Mendonca G, de Moura Gallo CV, Rebeiro Pinto LF: CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women. Toxicology Letters. 2006, 164: 90-95. 10.1016\/j.toxlet.2005.11.014.","journal-title":"Toxicology Letters"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-10-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-10-139\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-10-139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-10-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:04:50Z","timestamp":1630458290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-10-139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-10-139","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"5 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"139"}}